GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (OTCPK:RADLY) » Definitions » Enterprise Value

Raia Drogasil (Raia Drogasil) Enterprise Value : $9,699 Mil (As of May. 21, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Raia Drogasil Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Raia Drogasil's Enterprise Value is $9,699 Mil. Raia Drogasil's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $412 Mil. Therefore, Raia Drogasil's EV-to-EBIT ratio for today is 23.53.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Raia Drogasil's Enterprise Value is $9,699 Mil. Raia Drogasil's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $681 Mil. Therefore, Raia Drogasil's EV-to-EBITDA ratio for today is 14.24.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Raia Drogasil's Enterprise Value is $9,699 Mil. Raia Drogasil's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $7,145 Mil. Therefore, Raia Drogasil's EV-to-Revenue ratio for today is 1.36.


Raia Drogasil Enterprise Value Historical Data

The historical data trend for Raia Drogasil's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil Enterprise Value Chart

Raia Drogasil Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,972.42 8,908.98 8,483.06 8,761.28 13,716.54

Raia Drogasil Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,383.19 10,850.73 10,143.17 13,716.54 9,954.41

Competitive Comparison of Raia Drogasil's Enterprise Value

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil's Enterprise Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Enterprise Value falls into.



Raia Drogasil Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Raia Drogasil's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Raia Drogasil's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raia Drogasil  (OTCPK:RADLY) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Raia Drogasil's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=9698.998/412.173
=23.53

Raia Drogasil's current Enterprise Value is $9,699 Mil.
Raia Drogasil's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $412 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Raia Drogasil's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=9698.998/680.97
=14.24

Raia Drogasil's current Enterprise Value is $9,699 Mil.
Raia Drogasil's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $681 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Raia Drogasil's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=9698.998/7144.902
=1.36

Raia Drogasil's current Enterprise Value is $9,699 Mil.
Raia Drogasil's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $7,145 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raia Drogasil Enterprise Value Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil (Raia Drogasil) Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (Raia Drogasil) Headlines

From GuruFocus

Raia Drogasil SA Day Transcript

By GuruFocus Research 02-14-2024

Q3 2019 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2020 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2020 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2023 Raia Drogasil S/A Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2022 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2022 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2021 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2022 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2018 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024